Peter P De Cruz

Loading... 2 0 20 0 false
Credit Name
Peter P De Cruz
Full Name
De Cruz, Peter P
 
Variants
De Cruz, Peter
 
 
Loading... 3 0 20 0 false

Publications

Results 21-40 of 55 (Search time: 0.01 seconds).

Publication YearTitleAuthor(s)
217-Dec-2021Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trial.Schulberg, Julien D; Wright, Emily K; Holt, Bronte A; Hamilton, Amy L; Sutherland, Tom R; Ross, Alyson L; Vogrin, Sara; Miller, Ashley M; Connell, William C; Lust, Mark; Ding, Nik S; Moore, Gregory T; Bell, Sally J; Shelton, Edward; Christensen, Britt; De Cruz, Peter P ; Rong, Yuwei J; Kamm, Michael A
2213-Nov-2021Recommendations for Standardizing Clinical Trial Design and Endoscopic Assessment in Postoperative Crohn's Disease.Hanzel, Jurij; Jairath, Vipul; De Cruz, Peter P ; Guizzetti, Leonardo; Shackelton, Lisa M; Bossuyt, Peter; Duijvestein, Marjolijn; Dulai, Parambir S; Grossmann, Johannes; Hirten, Robert P; Khanna, Reena; Panes, Julian; Peyrin-Biroulet, Laurent; Regueiro, Miguel; Rubin, David T; Singh, Siddharth; Stidham, Ryan W; Sandborn, William J; Feagan, Brian G; D'Haens, Geert R; Ma, Christopher
2319-Aug-2021Combined Targeted Treatment Using Biologic-Tofacitinib Co-Therapy in Chronic Active Ulcerative Colitis.Hilley, Patrick ; Gilmore, Robert B ; Srinivasan, Ashish ; Choy, Matthew C ; De Cruz, Peter P 
2410-Aug-2021Higher anti-tumour necrosis factor-α levels correlate with improved radiological outcomes in Crohn's perianal fistulas.De Gregorio, Michael; Lee, Tanya; Krishnaprasad, Krupa; Amos, Gregory; An, Yoon-Kyo; Bastian-Jordan, Matthew; Begun, Jakob; Borok, Nira; Brown, Dougal J M; Cheung, Wa; Connor, Susan J; Gerstenmaier, Jan; Gilbert, Lauren E; Gilmore, Robert B ; Gu, Bonita; Kutaiba, Numan ; Lee, Allan; Mahy, Gillian; Srinivasan, Ashish ; Thin, Lena; Thompson, Alexander J; Welman, Christopher J; Yong, Eric X Z; De Cruz, Peter P ; van Langenberg, Daniel; Sparrow, Miles P; Ding, Nik S
257-Jul-2021Endoscopic Prediction of Crohn's Disease Postoperative Recurrence.De Cruz, Peter P ; Hamilton, Amy L; Burrell, Kathryn J; Gorelik, Alexandra; Liew, Danny; Kamm, Michael A
261-Jul-2021P-39: Health Care Costs Associated with Australian Home Parenteral Nutrition.Gilmore, Robert B ; Ma, Ronald ; Chapman, Brooke ; Hamilton, K; Testro, Adam G ; De Cruz, Peter P ; Wong, Darren
27Jun-2021Tofacitinib is Safe and Effective When Used in Combination With Infliximab for the Management of Refractory Ulcerative Colitis.Gilmore, Robert B ; Hilley, Patrick ; Srinivasan, Ashish ; Choy, Matthew C ; Grace, Josephine A ; De Cruz, Peter P 
28May-2021Impact of inflammatory bowel disease and azathioprine on long-term outcomes after liver transplantation for primary sclerosing cholangitis.Peverelle, Matthew R ; De Cruz, Peter P ; Paleri, Sarang; Gow, Paul J 
29May-2021Real-World Effectiveness of Ustekinumab Dose Intensification in Crohn's Disease.Srinivasan, Ashish ; van Langenberg, Daniel; De Cruz, Peter P 
30Apr-2021Anti-TNF-associated immunogenicity: use a retroactive drug but a proactive approach.Srinivasan, Ashish ; De Cruz, Peter P ; van Langenberg, Daniel R
3111-Mar-2021A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to Conceive.Flanagan, Emma; Wright, Emily K; Sparrow, Miles P; Moore, Gregory T; Connell, William R; De Cruz, Peter P ; Christensen, Britt; Shelton, Edward; Kamm, Michael A; Ward, Mark G; Dowling, Damian; Brown, Steven; Kashkooli, Soleiman; Thompson, Alexander J; Ross, Alyson L; Kiburg, Katerina V; Bell, Sally J
3225-Feb-2021Development and Feasibility of a Web-Based Decision Aid for Patients With Ulcerative Colitis: Qualitative Pilot Study.Kim, Andrew H; Girgis, Afaf; De Cruz, Peter P ; Siegel, Corey A; Karimi, Neda; Ruban, Sasha O; Sechi, Alexandra J; Ng, Wa Sang Watson; Andrews, Jane M; Connor, Susan J
3319-Nov-2020Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes.Peverelle, Matthew R ; Paleri, Sarang; Hughes, Jed ; De Cruz, Peter P ; Gow, Paul J 
341-Nov-2020Luminal microbiota related to Crohn's disease recurrence after surgery.Hamilton, Amy L; Kamm, Michael A; De Cruz, Peter P ; Wright, Emily K; Feng, Hai; Wagner, Josef; Sung, Joseph J Y; Kirkwood, Carl D; Inouye, Michael; Teo, Shu-Mei
355-Oct-2020Ustekinumab is a safe and effective biologic agent for Crohn's disease in a Liver Transplant patient.Peverelle, Matthew R ; Asadi, Khashayar ; De Cruz, Peter P 
36Sep-2020Immune therapies in ulcerative colitis: are we beyond anti-TNF yet?Raine, Tim; Verstockt, Bram; De Cruz, Peter P 
3714-Aug-2020Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford.Pulusu, Samba Siva Reddy; Srinivasan, Ashish ; Krishnaprasad, Krupa; Cheng, Daniel; Begun, Jakob; Keung, Charlotte; Van Langenberg, Daniel; Thin, Lena; Mogilevski, Tamara; De Cruz, Peter P ; Radford-Smith, Graham; Flanagan, Emma; Bell, Sally; Kashkooli, Soleiman; Sparrow, Miles; Ghaly, Simon; Bampton, Peter; Sawyer, Elise; Connor, Susan; Rizvi, Quart-Ul-Ain; Andrews, Jane M; Mahy, Gillian; Chivers, Paola; Travis, Simon; Lawrance, Ian Craig
38Aug-2020Letter: ustekinumab dose intensification for loss of response-should we re-induce before shortening the dose interval?Srinivasan, Ashish ; De Cruz, Peter P ; van Langenberg, Daniel R
39Aug-2020Letter: choosing between ustekinumab and vedolizumab in anti-TNF refractory Crohn's disease-the devil is in the detail.Srinivasan, Ashish ; De Cruz, Peter P ; van Langenberg, Daniel R
4017-Jul-2020Using Ustekinumab to Treat Crohn's Disease-Related Orofacial Granulomatosis: Two Birds, One Stone.Gilmore, Robert B ; Li Wai Suen, Christopher F D; Elliott, Tim; De Cruz, Peter P ; Srinivasan, Ashish